EMC Instytut Medyczny SA
WSE:EMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (22), the stock would be worth zł-19.92 (281% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -12.2 | zł11 |
0%
|
| 3-Year Average | 22 | zł-19.92 |
-281%
|
| Industry Average | 32.4 | zł-29.3 |
-366%
|
| Country Average | 18.5 | zł-16.69 |
-252%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| PL |
E
|
EMC Instytut Medyczny SA
WSE:EMC
|
469.5m PLN | -12.2 | 38.4 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.8B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.9B USD | 9.4 | 11.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.7B USD | 29.2 | 30.7 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 7.5 |
| Median | 18.5 |
| 70th Percentile | 27.4 |
| Max | 2 825.7 |
Other Multiples
EMC Instytut Medyczny SA
Glance View
EMC Instytut Medyczny SA engages in the management of hospitals and other healthcare facilities. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 2,072 full-time employees. The company went IPO on 2005-07-29. The firm offers a range of services, including the professional treatment of obesity, hernia, knee surgery, hip replacement and various plastic surgeries. The company also provides such diagnostic services as laboratory tests, diagnostic imaging (X-ray and ultrasonography), colonoscopy, gastroscopy and capsule endoscopy, as well as consultancy services with a range of specialists. In addition, it provides the prophylaxis programs. The firm operates hospitals and outpatient specialty and care clinics. The company operates such subsidiaries as: Lubmed Sp z o o, Mikulicz Sp z o o, EMC Silesia Sp z o o, PCZ Kowary Sp z o o and EMC Health Care Limited, among others. On January 3, 2014, CareUp BV acquired 68.41% stake in the Company due to the acquisition of Soporto Invest BV. On February 11, 2014, the Company acquired Regionalne Centrum Zdrowia Sp z o o.
